The anti-hyperglycemic property of different ginseng partitions > Volume 05 - 2005

본문 바로가기

사이트 내 전체검색


 » New Articles(2011~Present)
 » Articles (2001~2010)
      ∙ Volume 10 - 2010
      ∙ Volume 09 - 2009
      ∙ Volume 08 - 2008
      ∙ Volume 07 - 2007
      ∙ Volume 06 - 2006
      ∙ Volume 05 - 2005
      ∙ Volume 04 - 2004
      ∙ Volume 03 - 2003
      ∙ Volume 02 - 2002
      ∙ Volume 01 - 2001
 

Oriental Pharmacy and Experimental Medicine
Volume 05 - 2005
Date: 2005

Journal: Pages 1-15

March 2005 | The anti-hyperglycemic property of different ginseng partitions…

Jing-Tian Xie1,2, Chong-Zhi Wang1,2, Stephen Kim1,2 and Chun-Su Yuan1,2,3*

첨부파일

Summary

​Ginseng is a popular medicinal plant highly valued throughout the world. Asian ginseng is one ofthe most common species of ginseng. It has long occupied a significant position in orientalmedicine and has been justified its name as the “king herb”. As a nutritional supplement, ginsengis an extremely common and popular herbal medicine in the United States and Canada in recentdecades. The multiple constituents of ginseng possess equally multifaceted pharmacological actions asdemonstrated by numerous studies. Ginseng root and its constituents influenced the central nervoussystem, endocrine, cardiovascular, gastrointestinal system, sexual, renal organ and immune system,etc. One important action is its anti-hyperglycemic effect. Previous studies on ginseng demonstrate thatonly the root of ginseng has been used in the treatment of diabetes, while the other parts ofginseng plant were always neglected. Recently, we analyzed the constituents of ginseng berry,leaf and discovered that ginseng berry, leaf extracts and its total ginsenosides have the ability toreduce hyperglycemia and body weight and increase the peripheral glucose utilization in obeseor diabetic ob/ob or db/db mice. Our data suggest that all parts of ginseng plant, including root,berry, leaf and stem exhibit potent anti-hyperglycemic and anti-obese effects and may provide anopportunity to develop a novel class of anti-diabetic agents.


This website Copyright (c) 2014 Institute of Korean Medicine Kyung Hee University All rights reserved.
Top View
Mobile View